RAPT Therapeutics (RAPT) Peer Comparison

$58.01

$0.00 (0.00%)

As on 06-Mar-2026 09:30EDT

Market cap

$1,680 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

11.1

Div. Yield

0 %

Edit

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Market cap ($ Mln)	1,680	1,005
Revenue ($ Mln)	--	1
Net Profit ($ Mln)	-105.64	-106.61
Net Margin (%)	--	-7,362.36
RoE (%)	-64.15	-50.41
Price to Earnings	--	--
Price-To-Book	11.05	5.25

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Operating Revenue	0.00	1.45
Cost of Revenue	0.20	0.68
Gross Profit	-3.54	-1.35
Operating Expenses	112.44	116.72
Operating Profit (EBIT)	-112.64	-116.72
Other Income	0.00	0.00
Profit before Tax	-105.64	-106.61
Provision for Tax	0.00	0.00
Profit after Tax (Net Income)	-105.64	-106.61
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Shareholder's Funds	151.98	191.36
Minority Interest	0.00	0.00
Non-Current Liabilities	0.39	8.84
Current Liabilities	13.38	11.26
Total Liabilities	240.33	276.56

Assets ($ Mln)

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Non-Current Assets	4.69	10.37
Current Assets	161.05	201.09
Total Assets	240.33	276.56
Total Debt*	2.60	10.02
Net Current Assets	147.67	189.84

Cashflow ($ Mln)

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Cash From Operating Activities	-83.30	-130.87
Cash Flow from Investing Activities	52.70	-15.51
Cash from Financing Activities	152.85	122.12
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
ROCE (%)	-74.56	-51.84
ROE (%)	-64.15	-50.41
ROA (%)	-70.91	-39.77
EBIT Margin (%)	--	-7,919.68
Net Margin (%)	--	-7,362.36
Cash Profit Margin (%)	--	-0.01

Growth Ratios

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Revenue Growth (%)	--	34.57
EBIT Growth (%)	5.14	31.07
Net Profit Growth (%)	1.73	30.10
EPS Growth (%)	50.23	36.65
Book Value Growth (%)	-71.30	-31.97

Valuation Ratios

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Price / Earnings	-0.07	-1.15
Price / Book Value	0.05	0.61
Dividend Yield (%)	--	--
EV/EBITDA	1.61	0.35
Market Cap ($ Cr)	--	--

Solvency Ratios

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.01	0.01
Current Ratio	12.04	17.86
Quick Ratio	12.04	17.86
Interest Coverage	--	--

Operating Efficiency Ratios

	RAPT Therapeutics (RAPT)	Ventyx Biosciences (VTYX)
Debtors to sales (%)	--	34.53
Asset Turnover	0.00	0.01
Receivable days	--	--
Inventory Days	--	-216.77
Payable days	332.89	1,203.86
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly